Posts in tag

warfarin


Debbie Rigby rounds up the latest in research news  Proton pump inhibitors co‐prescribed with warfarin reduce warfarin control as measured by time in therapeutic range Results from retrosepctive data of …

Evidence that hospital pharmacists can prescribe to the same standards as doctors: study New Australia research provides low to moderate evidence that pharmacists can prescribe to the same standards as …

Debbie Rigby rounds up the latest in research news Effects of aspirin on risks of vascular events and cancer according to bodyweight and dose In this study analysis of individual …

Debbie Rigby takes a look at the latest in research news Risks and benefits of direct oral anticoagulants versus warfarin In this large prospective cohort study apixaban was found to …

Pharmacists have been reminded that first-generation oral sedating antihistamines are not approved for use in kids under two Following a coronial hearing of a fatal case involving a 74-day-old infant …

A new type of drug used to treat blood clots does not put patients at a higher bleeding risk than warfarin, researchers have found Recent trials have shown similar effectiveness …

Debbie Rigby rounds up the latest in research news  Alterations in fecal microbiota composition by probiotic supplementation in healthy adults A systematic review of 7 randomised controlled trials has demonstrated …

Quantifying the true effect of a drug on the population goes beyond looking at the short-term results of clinical trials, says doc A Sydney cardiologist has pointed out the importance …

Debbie Rigby presents the latest in research news Non-major bleeding with apixaban versus warfarin in patients with atrial fibrillation In ARISTOTLE study, non-major bleeding was common and substantially less frequent …

But NOACs have contributed to an overall growth in the anticoagulant market Based on the volume of prescriptions, use of novel oral anticoagulants (NOACs) in Australia has grown since their …

Clinical trials have shown that novel oral anticoagulants (NOACs) are as efficacious as warfarin in reducing the risk of stroke in patients with atrial fibrillation, reports the MJA. Notwithstanding, the …